Crossject (ALCJ) — Cash Flow-to-Debt Ratio
Crossject (ALCJ) has a Cash Flow-to-Debt Ratio of -0.09x as of December 2025, meaning its operating cash flow of €-3.12 Million could theoretically repay 0% of its total liabilities (€35.30 Million) in one year. See ALCJ current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Crossject Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Crossject across 14 annual periods. Also explore ALCJ shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Crossject (2012–2025)
Year-by-year debt coverage analysis for Crossject. For market capitalisation and broader financial context, see Crossject market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.18x | €-6.35 Million | €35.30 Million | ▲ +22.6% |
| 2024 | -0.23x | €-7.96 Million | €34.24 Million | ▼ -27.1% |
| 2023 | -0.18x | €-6.20 Million | €33.91 Million | ▼ -8.6% |
| 2022 | -0.17x | €-5.08 Million | €30.17 Million | ▼ -2.4% |
| 2021 | -0.16x | €-6.08 Million | €37.01 Million | ▼ -4.5% |
| 2020 | -0.16x | €-5.46 Million | €34.72 Million | ▲ +38.7% |
| 2019 | -0.26x | €-5.51 Million | €21.48 Million | ▲ +40.8% |
| 2018 | -0.43x | €-8.02 Million | €18.50 Million | ▼ -1.3% |
| 2017 | -0.43x | €-4.97 Million | €11.63 Million | ▲ +22.6% |
| 2016 | -0.55x | €-4.40 Million | €7.97 Million | ▲ +41.4% |
| 2015 | -0.94x | €-4.80 Million | €5.08 Million | ▼ -16.1% |
| 2014 | -0.81x | €-3.16 Million | €3.89 Million | ▼ -296.6% |
| 2013 | -0.21x | €-964.00K | €4.70 Million | ▼ -62.0% |
| 2012 | -0.13x | €-569.06K | €4.50 Million | — |